Peptide Laws in Colombia
CO · Americas · 23 peptides tracked
Are Peptides Legal in Colombia?
Colombia is a popular medical tourism destination and INVIMA regulation is moderate, with enforcement that has tightened noticeably during 2026. Clinics in Bogota and Medellin offer peptide therapies and registered medicines are available on prescription. On 25 June 2026 INVIMA issued a public health alert naming six unregistered weight-loss products being sold through social media, messaging apps and digital platforms: retatrutide (two presentations), tirzepatide 10 mg injection, GHK-Cu peptide solution, a LIPO-C plus B12 combination injection, and NAD+ 10 mg/mL solution. INVIMA stated that none hold sanitary registration, that their commercialisation in Colombia is therefore illegal, and that they are considered fraudulent products. The agency reported adverse events including dizziness, fainting, menstrual irregularities, weight gain and altered lipid profiles, and said it would continue inspection, surveillance and control action to remove such products from the market. It has referred cases to the Fiscalia for criminal investigation. The practical position: a product with INVIMA sanitary registration, prescribed and dispensed through the formal system, is lawful. A peptide bought through Instagram or a messaging app is not, and is now actively being pursued.
4
Legal11
Grey Area2
Prescription6
BannedCan You Buy Peptides in Colombia?
4 peptide(s) are legal to buy in Colombia, including GHK-Cu, NAD+, Glutathione, Vitamin B12. 2 peptide(s) require a valid prescription, including Tirzepatide, Semaglutide. 11 peptide(s) fall into a legal grey area: Selank, MOTS-c, Semax, AOD-9604, DSIP, and 6 more. These may be available for research purposes but their legality for personal use is ambiguous. 6 peptide(s) are banned: TB-500, Ipamorelin, CJC-1295, BPC-157, Retatrutide, and 1 more. Purchasing or possessing these is illegal.
Traveling to Colombia with Peptides
When traveling to Colombia with peptides, the legality depends on each peptide's classification. Do not bring banned substances (TB-500, Ipamorelin, CJC-1295, BPC-157, Retatrutide, and 1 more) — these could result in criminal penalties at customs. Prescription peptides (Tirzepatide, Semaglutide) typically require documentation such as a prescription or doctor's letter when crossing borders. Enforcement in Colombia is rated as "Moderate." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Colombia? Get verified wholesale quotes on peptide.broker →
Traveling to Colombia with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Colombia
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Tirzepatide | Prescription | Yes | INVIMA Registered | INVIMA registered. Prescription required. | Secondary |
| Selank | Grey Area | No | Unregistered | Russian nootropic. Not available through mainstream channels. | Secondary |
| MOTS-c | Grey Area | No | Unregistered | Not specifically regulated. Minimal availability. | Secondary |
| TB-500 | Banned | No | Producto Fraudulento | Classified as a "producto farmaceutico fraudulento" by operation of Decreto 677 de 1995 art. 2(g) - any pharmaceutical product not covered by a Registro Sanitario. INVIMA issued Alerta 184-2026 (24 June 2026) and Alerta 252-2026 (19 August 2026) naming BPC-157, TB-500, Ipamorelin, CJC-1295, Retatrutida, DSIP, Selank, Semax, PT-141, GHK-Cu, Tesamorelin, MOTS-C, NAD+, IGF-1, Cagrilintide, AOD-9604 and Kisspeptin, stating their commercialisation in Colombia is illegal. INVIMA addresses the framing directly: these are sold as "research chemicals", supplements or magistral preparations without having completed the regulatory processes required to be considered authorised medicines. | Official |
| GHK-Cu | Legal | No | Cosmetic | Topical cosmetic use is unrestricted. Injectable GHK-Cu solution is a different matter: INVIMA named it in its 25 Jun 2026 alert as an unregistered product whose sale in Colombia is illegal and fraudulent. The cosmetic and injectable forms are not treated alike. | Secondary |
| Ipamorelin | Banned | No | Producto Fraudulento | Classified as a "producto farmaceutico fraudulento" by operation of Decreto 677 de 1995 art. 2(g) - any pharmaceutical product not covered by a Registro Sanitario. INVIMA issued Alerta 184-2026 (24 June 2026) and Alerta 252-2026 (19 August 2026) naming BPC-157, TB-500, Ipamorelin, CJC-1295, Retatrutida, DSIP, Selank, Semax, PT-141, GHK-Cu, Tesamorelin, MOTS-C, NAD+, IGF-1, Cagrilintide, AOD-9604 and Kisspeptin, stating their commercialisation in Colombia is illegal. INVIMA addresses the framing directly: these are sold as "research chemicals", supplements or magistral preparations without having completed the regulatory processes required to be considered authorised medicines. | Official |
| Semaglutide | Prescription | Yes | INVIMA Registered | INVIMA registered. Ozempic/Wegovy available. Prescription required with sanitary registration compliance. | Secondary |
| CJC-1295 | Banned | No | Producto Fraudulento | Classified as a "producto farmaceutico fraudulento" by operation of Decreto 677 de 1995 art. 2(g) - any pharmaceutical product not covered by a Registro Sanitario. INVIMA issued Alerta 184-2026 (24 June 2026) and Alerta 252-2026 (19 August 2026) naming BPC-157, TB-500, Ipamorelin, CJC-1295, Retatrutida, DSIP, Selank, Semax, PT-141, GHK-Cu, Tesamorelin, MOTS-C, NAD+, IGF-1, Cagrilintide, AOD-9604 and Kisspeptin, stating their commercialisation in Colombia is illegal. INVIMA addresses the framing directly: these are sold as "research chemicals", supplements or magistral preparations without having completed the regulatory processes required to be considered authorised medicines. | Official |
| Semax | Grey Area | No | Unregistered | Russian nootropic. Not available through mainstream channels. | Secondary |
| BPC-157 | Banned | No | Producto Fraudulento | Classified as a "producto farmaceutico fraudulento" by operation of Decreto 677 de 1995 art. 2(g) - any pharmaceutical product not covered by a Registro Sanitario. INVIMA issued Alerta 184-2026 (24 June 2026) and Alerta 252-2026 (19 August 2026) naming BPC-157, TB-500, Ipamorelin, CJC-1295, Retatrutida, DSIP, Selank, Semax, PT-141, GHK-Cu, Tesamorelin, MOTS-C, NAD+, IGF-1, Cagrilintide, AOD-9604 and Kisspeptin, stating their commercialisation in Colombia is illegal. INVIMA addresses the framing directly: these are sold as "research chemicals", supplements or magistral preparations without having completed the regulatory processes required to be considered authorised medicines. | Official |
| NAD+ | Legal | No | Supplement | No INVIMA sanitary registration as an injectable. NAD+ 10 mg/mL solution was named in INVIMA's 25 Jun 2026 alert as an unregistered, fraudulent product being sold through social media and messaging apps. | Secondary |
| Retatrutide | Banned | No | Producto Fraudulento | Classified as a "producto farmaceutico fraudulento" by operation of Decreto 677 de 1995 art. 2(g) - any pharmaceutical product not covered by a Registro Sanitario. INVIMA issued Alerta 184-2026 (24 June 2026) and Alerta 252-2026 (19 August 2026) naming BPC-157, TB-500, Ipamorelin, CJC-1295, Retatrutida, DSIP, Selank, Semax, PT-141, GHK-Cu, Tesamorelin, MOTS-C, NAD+, IGF-1, Cagrilintide, AOD-9604 and Kisspeptin, stating their commercialisation in Colombia is illegal. INVIMA addresses the framing directly: these are sold as "research chemicals", supplements or magistral preparations without having completed the regulatory processes required to be considered authorised medicines. | Official |
| AOD-9604 | Grey Area | No | Unregistered | Not specifically regulated. | Secondary |
| Glutathione | Legal | No | Supplement | — | Unsourced |
| DSIP | Grey Area | No | Unregistered | — | Unsourced |
| Epithalon | Grey Area | No | Unregistered | — | Unsourced |
| KPV | Grey Area | No | Unregistered | — | Unsourced |
| HGH | Grey Area | No | Unregistered | — | Unsourced |
| Liraglutide | Grey Area | No | Unregistered | — | Unsourced |
| Melanotan II | Grey Area | No | Unregistered | — | Unsourced |
| MK-677 | Banned | No | Producto Fraudulento | Classified as a "producto farmaceutico fraudulento" by operation of Decreto 677 de 1995 art. 2(g) - any pharmaceutical product not covered by a Registro Sanitario. INVIMA issued Alerta 184-2026 (24 June 2026) and Alerta 252-2026 (19 August 2026) naming BPC-157, TB-500, Ipamorelin, CJC-1295, Retatrutida, DSIP, Selank, Semax, PT-141, GHK-Cu, Tesamorelin, MOTS-C, NAD+, IGF-1, Cagrilintide, AOD-9604 and Kisspeptin, stating their commercialisation in Colombia is illegal. INVIMA addresses the framing directly: these are sold as "research chemicals", supplements or magistral preparations without having completed the regulatory processes required to be considered authorised medicines. | Official |
| Vitamin B12 | Legal | No | Supplement | — | Unsourced |
| PT-141 | Grey Area | No | Unregistered | — | Unsourced |
About the sources on this page
Entries marked Official cite a government regulator, legislation or an official gazette. Entries marked Secondary rest on consultancy, law firm, news or academic reporting rather than the regulator itself. Some entries currently carry no source at all.
We show these entries rather than hiding them, but they should not be relied on. Nothing on this site is legal advice. Verify against the national regulator before acting, and if you can point us at a better source please submit an update.
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.